Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

H.I.G. BioHealth Partners

Investor type Venture Capital
Founders Sami Mnaymneh Tony Tamer


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Looking for a perfect list of funds?

Get recommendations from our smart algorithm

Get the list
Total investments 26
Average round size
The average size of a deal this fund participated in
Portfolio companies 17
Rounds per year 2.36
Lead investments 7
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 6
Key employees 5
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Health Care
  • Biotechnology
  • Medical Device
  • Pharmaceutical
  • Medical

The main department of described VC is located in the Miami. The venture was found in North America in United States.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight Arvelle Therapeutics, On Target Laboratories, NeuWave Medical. Among the most popular fund investment industries, there are Pharmaceutical, Medical Device. The fund has exact preference in a number of founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. Besides, a startup needs to be aged 6-10 years to get the investment from the fund.

This organization was formed by Sami Mnaymneh, Tony Tamer. Besides them, we counted 5 critical employees of this fund in our database.

Considering the real fund results, this VC is 21 percentage points more often commits exit comparing to other organizations. This H.I.G. BioHealth Partners works on 11 percentage points less the average amount of lead investments comparing to the other organizations. The top activity for fund was in 2015. Despite it in 2019 the fund had an activity. The common things for fund are deals in the range of 10 - 50 millions dollars. The top amount of exits for fund were in 2016. The fund is generally included in 2-6 deals every year.

The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the H.I.G. BioHealth Partners, startups are often financed by Quaker Partners, New Enterprise Associates, MPM Capital. The meaningful sponsors for the fund in investment in the same round are New Enterprise Associates, Versant Ventures, Quaker Partners. In the next rounds fund is usually obtained by Quaker Partners, New Enterprise Associates, OUP (Osage University Partners).

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of H.I.G. BioHealth Partners:
Typical Co-investors
H.I.G. BioHealth Partners is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after H.I.G. BioHealth Partners:

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Aesop Capital California, San Francisco, United States
Enabling Technology Fund B.V. -
Foton Daimler Automotive Beijing, China, Huairou
Jemison Investment Company Alabama, Birmingham, United States
John Nurminen Oy Finland, Helsinki, Southern Finland
Lloyd's Lab England, London, United Kingdom
MAN Truck & Bus Bayern, Germany, Munich
Miyazaki Taiyo Capital Japan, Miyazaki, Miyazaki Prefecture
Neurato Investments -
Omega Funds Boston, Massachusetts, United States
Paribas Deelnemingen -
Pepper Media Holding Berlin, Berlin, Germany
SDG Invest -
Shenzhen Qianhai Huaye Yuan Touzi China, Guangdong, Shenzhen
TrustCapital India, Maharashtra, Mumbai
Ufi Ventures England, London, United Kingdom
Zhongshan Qingqi Chuangtou Anhui, China, Zhongshan

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Click Therapeutics

Health Care
Information Technology
Medical Device
Other Healthcare Technology Systems
$52M22 Oct 2021 New York, New York, United States

Arvelle Therapeutics

$42M27 May 2020 Basel, Basel-City, Switzerland

Zerigo Health

Health Care
Health Diagnostics
Medical Device
$18M23 Oct 2019 San Diego, California, United States


Health Care
Health Diagnostics
$22M16 Jul 2019 Vista, California, United States

Intact Vascular

Health Care
Medical Device
$25M30 May 2019 Radnor Township, Pennsylvania, United States

Arvelle Therapeutics

$196M18 Feb 2019 Basel, Basel-City, Switzerland

Iconic Therapeutics

Drug Discovery
$4M15 Jun 2018 South San Francisco, California, United States

Neurana Pharmaceuticals

Health Care
$60M08 May 2018 San Diego, California, United States

Intact Vascular

Health Care
Medical Device
$20M16 Apr 2018 Radnor Township, Pennsylvania, United States


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent H.I.G. BioHealth Partners?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: